Royal Philips
Two-year data from the TOBA II BTK clinical trial demonstrate durability of dissection repair below the knee with the Philips Tack Endovascular System
Two-year data from the TOBA II BTK clinical trial demonstrate durability of dissection repair below the knee with the Philips Tack Endovascular System
June 3, 2021
has
a
Amsterdam, the Netherlands –
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced positive two-year results from the Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial. The data show the Philips Tack Endovascular System (4F), a first-of-its kind dissection repair device, provides a sustained treatment effect and positive impact on quality of life for Peripheral Artery Disease (PAD) and Critical Limb Ischemia (CLI) patients at two years. The data was presented by Co-Principal Investigator George Adams, MD, Interventional Cardiologist at Rex Hospital affiliated with the Universit
ROCC Communication Collaboration June 2, 2021 Partnership leverages Philips’ latest Radiology Operations Command Center to improve the access, quality, and productivity of Akumin’s outpatient imaging center network Amsterdam, the Netherlands and Plantation, U.S. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Akumin Inc., a leading provider of outpatient diagnostic imaging services in the U.S., today announced a strategic collaboration to deploy Philips’ new Rad
Investegate announcements from Royal Philips, Philips and Akumin partner to advance radiology performance and quality, and reimagine radiology network ecosystems
June 2, 2021 Partnership leverages Philips' latest Radiology Operations Command Center to improve the access, quality, and productivity of Akumin's outpatient imaging center network Amsterdam,
May 27, 2021 Amsterdam, The Netherlands and Madrid, Spain - Royal Philips, one of Spain's leading private hospital groups, today announced that Philips has been selected to install the latest